The global toxoid vaccines market is entering a pivotal phase of growth as public health initiatives shift toward life-course immunization. Unlike live-attenuated vaccines, toxoid vaccines utilize inactivated toxins (toxoids) produced by bacteria to build immunity. These are foundational in preventing life-threatening conditions such as Tetanus and Diphtheria. Market...